• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Hospital Uses Google Glass To Diagnose Skin Conditions

by Fred Pennic 04/16/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Hospital Uses Google Glass To Diagnose Skin Conditions
Credit: William Murphy, Rhode Island Hospital
A team of physicians at Rhode Island Hospital conducted a research trail with Google Glass to gauge the effectiveness, security and patient acceptance of a real-time, video skin consultation. The study began in March, 2014 and concluded after six months. The research results were recently published this week in JAMA Dermatology.

Study Overview

For the patients who qualified for the trial, the emergency department physicians at the Rhode Island Hospital used Google Glass to contact a dermatologist through a video link using Glass and utilizing Pristine’s HIPAA compliant platform. Medical staff explained to patients that no information was being stored, and the live transmission was encrypted. After the consultation, patients were surveyed about their experience with teledermatology. Patients reported that while they prefer in-person visits, they preferred the video consult over the traditional phone consult. They also reported that they felt their information was safe. 

Study Limitations

The study did report several limitations including: – Because of the small size and single-site status, results cannot be generalized to other institutions; – the accuracy of the diagnosis in the cases wasn’t measured – financial and workflow effects of the device weren’t addressed “A device like this democratises telemedicine because a hospital can start a programme with little money and gain access to an experience that was only previously available at a much higher price point,” said Paul S Porter, principal investigator. Because of the interactive nature of using Glass, the teledermatologists were able to appreciate both non-specific skin eruptions and skin diseases. Additionally, the off-site doctors were able to interact with the on-site doctors by asking questions and requesting additional skin locations to examine. Rhode Island Hospital was the first hospital in the US to test Google Glass in an emergency department setting.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |